Skip Navigation


Human Molecular Genetics Advance Access originally published online on July 17, 2007
Human Molecular Genetics 2008 17(5):631-641; doi:10.1093/hmg/ddm188
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
17/5/631    most recent
ddm188v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Farrington-Rock, C.
Right arrow Articles by Krakow, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Farrington-Rock, C.
Right arrow Articles by Krakow, D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Disruption of the Flnb gene in mice phenocopies the human disease spondylocarpotarsal synostosis syndrome

Claire Farrington-Rock1, Veneta Kirilova1, Lisa Dillard-Telm2, Alexander D. Borowsky2,3, Sara Chalk2, Matthew J. Rock1, Daniel H. Cohn1,4,5 and Deborah Krakow1,4,6,*

1 Medical Genetics Institute, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, SSB-371, Los Angeles, CA 90048, USA 2 Center for Comparative Medicine and Mouse Biology Program and 3 Department of Pathology and Laboratory Medicine, UC Davis School of Medicine, Davis, CA 95616, USA 4 Department of Human Genetics 5 Department of Pediatrics and 6 Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA

* To whom correspondence should be addressed. Tel: +1 3104236460; Fax: +1 3104230620; Email: deborah.krakow{at}cshs.org

Received May 26, 2007; Accepted July 12, 2007

Spondylocarpotarsal synostosis syndrome (SCT) is an autosomal recessive disease that is characterized by short stature, and fusions of the vertebrae and carpal and tarsal bones. SCT results from homozygosity or compound heterozygosity for nonsense mutations in FLNB. FLNB encodes filamin B, a multifunctional cytoplasmic protein that plays a critical role in skeletal development. Protein extracts derived from cells of SCT patients with nonsense mutations in FLNB did not contain filamin B, demonstrating that SCT results from absence of filamin B. To understand the role of filamin B in skeletal development, an Flnb–/– mouse model was generated. The Flnb–/– mice were phenotypically similar to individuals with SCT as they exhibited short stature and similar skeletal abnormalities. Newborn Flnb–/– mice had fusions between the neural arches of the vertebrae in the cervical and thoracic spine. At postnatal day 60, the vertebral fusions were more widespread and involved the vertebral bodies as well as the neural arches. In addition, fusions were seen in sternum and carpal bones. Analysis of the Flnb–/– mice phenotype showed that an absence of filamin B causes progressive vertebral fusions, which is contrary to the previous hypothesis that SCT results from failure of normal spinal segmentation. These findings suggest that spinal segmentation can occur normally in the absence of filamin B, but the protein is required for maintenance of intervertebral, carpal and sternal joints, and the joint fusion process commences antenatally.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.